title: DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin.
abstract: Rheumatoid arthritis (RA) occurs more frequently in HLA-DR4+ individuals than in those who do not express this MHC class II molecule. Although the role of this genetic factor in the immunopathology of this autoimmune disease is unclear, the association of RA with HLA-DR4 may indicate that DR4 molecules present autoantigen(s) to T cells. Here we report the analysis of naturally processed peptides, eluted from a mixture of HLA-DR4Dw4 (DRB1*0401) and DR53 (DRB4*0101) molecules isolated from an RA patient-derived EBV-transformed B cell line. Several (size variants of) self-peptides originating from the autologous molecules HLA-A2, HLA-Cw9, HLA-B62, HLA-DR4Dw4 and HLA-DR53, were identified. We also found a sequence that has no homology to any protein in the SwissProt protein sequence databank, and a peptide identical to an internal fragment of the autoantigen calreticulin. The association of the identified peptides with cells expressing HLA-DR4Dw4/DR53 was confirmed by peptide binding analysis. In agreement with previously described peptide binding motifs for DR4Dw4, most peptides contained an aromatic residue (Phe, Tyr, Trp) at relative position i and a small hydroxyl-containing residue (Ser, Thr) at i + 5. Our findings indicate that in RA patient-derived EBV-transformed B cells DR4Dw4/DR53 molecules present a peptide from the autoantigen calreticulin. Interestingly, autoantibodies against calreticulin have been found in various rheumatic diseases, including rheumatoid arthritis. Thus, the analysis of HLA class II-bound peptides can lead to the identification of putative T helper epitopes, which might be involved in the immunopathology of autoimmune diseases.
authors.affiliation: Department of Immunohaematology and Bloodbank, University Hospital Leiden, The Netherlands.
authors.forename: F A
authors.initials: FA
authors.lastname: Verreck
authors.forename: D
authors.initials: D
authors.lastname: Elferink
authors.forename: C J
authors.initials: CJ
authors.lastname: Vermeulen
authors.forename: R
authors.initials: R
authors.lastname: Amons
authors.forename: F
authors.initials: F
authors.lastname: Breedveld
authors.forename: R R
authors.initials: RR
authors.lastname: de Vries
authors.forename: F
authors.initials: F
authors.lastname: Koning
mesh_terms: D000595:Amino Acid Sequence; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001324:Autoantigens / Q000737:chemistry / Q000276:immunology; D002135:Calcium-Binding Proteins / Q000737:chemistry*; D037282:Calreticulin; D002461:Cell Line, Transformed; D006684:HLA-DR Antigens / Q000737:chemistry* / Q000276:immunology; D015804:HLA-DR4 Antigen / Q000737:chemistry* / Q000276:immunology; D059845:HLA-DRB4 Chains; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000032:analysis / Q000276:immunology; D011485:Protein Binding; D012261:Ribonucleoproteins / Q000737:chemistry*
chemical_list: D001324:Autoantigens; D002135:Calcium-Binding Proteins; D037282:Calreticulin; D006684:HLA-DR Antigens; D015804:HLA-DR4 Antigen; C050610:HLA-DR53; D059845:HLA-DRB4 Chains; D010455:Peptides; D012261:Ribonucleoproteins